SCHEMBL9946952

SCHEMBL9946952

CNC(=O)NCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18722155 0.83 EPHX1 (0.31) —
SCHEMBL4545266 0.77 KEAP1 (0.48) —
SCHEMBL6289553 0.77 — —
SCHEMBL1107279 0.77 — —
SCHEMBL13411696 0.76 KEAP1 (0.44) —
SCHEMBL15835883 0.75 — —
SCHEMBL28196877 0.75 — —
SCHEMBL19172568 0.75 KEAP1 (0.47) —
SCHEMBL12838131 0.73 LMNA (0.43) —
SCHEMBL868382 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149702-A1 INHIBITORS OF CELLULAR NECROSIS THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2012-06-14 — — US disclosed
US-20080004282-A1 Compositions and methods for modulating gated ion channels PAINCEPTOR PHARMA CORPORATION (CA) 2008-01-03 — — US disclosed
US-7273909-B2 Polyethylene glycol aldehydes HOFFMANN-LA ROCHE INC. (US) 2007-09-25 — — US disclosed
Send feedback